By Iain Gilbert
Date: Tuesday 27 Jan 2026
(Sharecast News) - Analysts at Citi initiated coverage of AstraZeneca and GSK on Tuesday, taking a bullish stance on the former but a more cautious view on the latter.
| Form 8.3 - NCC Group plc | 30-Jan-2026 | 10:48 | RNS |
| Form 8.5 (EPT/RI) - Oxford Biomedica plc | 30-Jan-2026 | 10:29 | RNS |
| Form 8.5 (EPT/NON-RI) - Oxford Biomedica plc | 30-Jan-2026 | 10:26 | RNS |
| Form 8.3 - NCC Group plc | 30-Jan-2026 | 09:44 | RNS |
| Form 8.5 (EPT/RI)-NCC Group plc | 30-Jan-2026 | 08:45 | GlobeNewswire NA |
| Questor:Meggitt | 23-Dec-2014 | Telegraph |
| Questor :KCOM | 27-Nov-2014 | Telegraph |
| Questor :Ricardo | 31-Oct-2014 | Telegraph |
| Questor:CSR | 17-Oct-2014 | Telegraph |
| Questor:BAE Systems | 03-Sep-2014 | Telegraph |
| Price | 5,914.84 |
| Change Today | 6.52 |
| % Change | 0.11 % |
| 29-Jan-26 Close | 5,908.32 |
You are here: research